Presentation THT 2025 Real-world Results with Barostim within a Multi-disciplinary Heart Failure Program Presenter: Patrick McCann February 11, 2025 REGISTER for free or LOG IN to view this content Heart Failure THT 2025 Up Next Presentation THT 2025 Residual Risk in HFpEF and the Potential Role of Interatrial Shunts Presenter: Javed Butler February 11, 2025 More slides + Presentation THT 2025 Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring Presenter: Sandip K. Zalawadiya February 11, 2025 Presentation THT 2025 Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results Presenter: Javed Butler February 11, 2025 We Recommend Disclosures NULL
Presentation THT 2025 Residual Risk in HFpEF and the Potential Role of Interatrial Shunts Presenter: Javed Butler February 11, 2025
Presentation THT 2025 Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring Presenter: Sandip K. Zalawadiya February 11, 2025
Presentation THT 2025 Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results Presenter: Javed Butler February 11, 2025